Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,058 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Among authors: canonica gw. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative.
Zuberbier T, Abdul Latiff A, Aggelidis X, Augustin M, Balan RG, Bangert C, Beck L, Bieber T, Bernstein JA, Bertolin Colilla M, Berardi A, Bedbrook A, Bindslev-Jensen C, Bousquet J, de Bruin-Weller M, Bruscky D, Buyuktiryaki B, Canonica GW, Castro C, Chanturidze N, Chong-Neto HJ, Chu CY, Chularojanamontri L, Cork M, Criado RFJ, Barredo LC, Custovic A, Darsow U, Emurlai A, de Pablo A, Del Giacco S, Girolomoni G, Deleva Jovanova T, Deleuran M, Douladiris N, Duarte B, Dubakiene R, Eller E, Engel-Yeger B, Ensina LF, Filho NR, Flohr C, Fomina D, Francuzik W, Galimberti ML, Giménez-Arnau AM, Godse K, Mortz CG, Gotua M, Hide M, Hoetzenecker W, Hunzelmann N, Irvine A, Jack C, Kanavarou I, Katoh N, Kinaciyan T, Kocatürk E, Kulthanan K, Lapeere H, Lau S, Machado Forti Nastri M, Makris M, Mansour E, Marsland A, Morelo Rocha Felix M, Moschione Castro AP, Nettis E, Nicolas JF, Nosbaum A, Odemyr M, Papapostolou N, Parisi CAS, Paudel S, Peter J, Pokharel P, Puig L, Quint T, Ramon GD, Regateiro F, Ricci G, Rosario C, Sackesen C, Schmid-Grendelmeier P, Serra-Baldrich E, Siemens K, Smith C, Staubach P, Stevanovic K, Su-Kücük Ö, Sussman G, Tavecchio S, Teovska Mitrevska N, Thaci D, Toubi E, Tr… See abstract for full author list ➔ Zuberbier T, et al. Among authors: canonica gw. Clin Transl Allergy. 2023 Sep;13(9):e12299. doi: 10.1002/clt2.12299. Clin Transl Allergy. 2023. PMID: 37746794 Free PMC article. Review.
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, Guttman-Yassky E, Metz M, Mullol J, Palomares O, Renz H, Ständer S, Zuberbier T, Maurer M. Kolkhir P, et al. Among authors: canonica gw. Nat Rev Drug Discov. 2023 Sep;22(9):743-767. doi: 10.1038/s41573-023-00750-1. Epub 2023 Aug 1. Nat Rev Drug Discov. 2023. PMID: 37528191 Review.
Update meta-analysis on the efficacy and safety issues of fexofenadine.
Gómez RM, Moreno P, Compalati E, Canonica GW, Ansotegui Zubeldia IJ. Gómez RM, et al. Among authors: canonica gw. World Allergy Organ J. 2023 Jul 11;16(7):100795. doi: 10.1016/j.waojou.2023.100795. eCollection 2023 Jul. World Allergy Organ J. 2023. PMID: 37546236 Free PMC article.
A2BCD: a concise guide for asthma management.
Lommatzsch M, Brusselle GG, Levy ML, Canonica GW, Pavord ID, Schatz M, Virchow JC. Lommatzsch M, et al. Among authors: canonica gw. Lancet Respir Med. 2023 Jun;11(6):573-576. doi: 10.1016/S2213-2600(22)00490-8. Epub 2023 Jan 27. Lancet Respir Med. 2023. PMID: 36716752 Review.
Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
Paoletti G, Casini M, Malvezzi L, Pirola F, Russo E, Nappi E, Muci GQ, Montagna C, Messina MR, Ferri S, Racca F, Lamacchia D, Cataldo G, Puggioni F, De Virgilio A, Ferreli F, Mercante G, Spriano G, Canonica GW, Heffler E. Paoletti G, et al. Among authors: canonica gw. J Investig Allergol Clin Immunol. 2023 Dec;33(6):457-463. doi: 10.18176/jiaci.0851. Epub 2022 Sep 1. J Investig Allergol Clin Immunol. 2023. PMID: 38095494 Free article.
COPD and biologic treatment: state of the art.
Ferri S, Paoletti G, Pelaia C, Heffler E, Canonica GW, Puggioni F. Ferri S, et al. Among authors: canonica gw. Curr Opin Allergy Clin Immunol. 2023 Aug 1;23(4):309-318. doi: 10.1097/ACI.0000000000000920. Epub 2023 Jun 20. Curr Opin Allergy Clin Immunol. 2023. PMID: 37357768 Review.
1,058 results